Navigation Links
SUNY Downstate receives award to develop mobile phone apps for stroke patients and their caregivers
Date:7/9/2012

SUNY Downstate Medical Center has received an award to enhance patient care in the field of neurology. Steven R. Levine, MD, professor of neurology and emergency medicine and vice chair of neurology, is scientific principal investigator on a $500,000 award from the federally funded Patient-Centered Outcomes Research Institute (PCORI) to develop mobile phone applications for stroke patients and their caregivers.

Investigators from SUNY Downstate's College of Medicine and School of Public Health are participating in this study, which is being developed in conjunction with the National Stroke Association and the Arthur Ashe Institute for Urban Health. The grant team will survey stroke survivors and their caregivers to investigate the interest in and preference for smartphone apps that facilitate improved identification and management of risk factors and healthcare needs.

"Despite the saying, 'There's an app for that,' progress has been limited in providing successful mobile technology to help patients manage cardiovascular and cerebrovascular diseases and other illnesses," said Dr. Levine. "Nevertheless, there is enormous potential for patients and their caregivers to improve health outcomes through this technology, including among the elderly, minorities, and those of limited financial means, who are often most in need of better care. We are looking to develop a model program that will address stroke risk and disease management that will be applicable to other conditions as well."

The two-year award is part of PCORI's Pilot Projects Program. The funding for SUNY Downstate has been approved pending completion of a business review and a formal award agreement with PCORI, which is an independent, nonprofit organization whose establishment was authorized by Congress in 2010. Its mission is to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed healthcare decisions.

Investigators include Dee Burton, PhD, associate professor and chair of community health sciences, School of Public Health; Abhishek Pandey, MD, clinical instructor in the Department of Medicine and sleep researcher with the Brooklyn Health Disparities Center (BHDC); Clotilde Balucani, MD, research fellow in the Department of Neurology; Ruth Browne, ScD, MPH, CEO of the Arthur Ashe Institute for Urban Health (AAIUH) and co-director, BHDC; and Marilyn Fraser-White, MD, associate director of research and training, AAIUH, and director of community engagement, BHDC.

As previously announced, Dr. Levine is also principal investigator on Downstate's NIH-funded clinical trial network involving the four SUNY medical center campuses. Among the aims of the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT) is the recruitment of a diverse patient population for neurology clinical trials and to train underrepresented minority investigators. This grant is also part of SUNY REACH, a collaborative effort involving the four SUNY academic medical centers and the SUNY College of Optometry.


'/>"/>

Contact: Ron Najman
ron.najman@downstate.edu
718-270-2696
SUNY Downstate Medical Center
Source:Eurekalert

Related medicine news :

1. Loyola Cancer Center receives Outstanding Achievement Award
2. MU receives national award for using mind-body approach to improve health
3. Neuropsychologist receives University of Houstons highest faculty honor
4. Boston researcher, surgical oncologist receives national award
5. LA BioMed receives Grand Challenges Explorations grant
6. Lawson researcher receives 1 of first-ever Pfizer Psychiatry Research Awards
7. Dr. Arthur Slutsky, vice-president of research at St. Michaels, receives lifetime award
8. UC San Diego Superfund Research Program receives $15 million grant renewal
9. Markey receives $6.25 million to study deadly blood and bone marrow disease
10. Feola, at University of Kentucky, receives NIH grant to study cystic fibrosis
11. UC Santa Barbaras Kavli Institute receives 2 grants to explore interface of physics and biology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... Vegas, NV (PRWEB) , ... April 25, 2017 ... ... can now choose a modern procedure that achieves results in a fraction of ... in Las Vegas, NV, with Significance Dental Specialists, now offers this revolutionary ...
(Date:4/25/2017)... GA (PRWEB) , ... April 25, 2017 , ... ... their neck and back pain with a reputable physician in their area, announces the ... CRM protects patient information for patients who are looking for reputable physicians to help ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a ... its patient care management module. Using this new feature, sleep physicians can now ... initiated on continuous positive airway pressure (CPAP), oral, or other forms of sleep ...
(Date:4/25/2017)... ... ... Vetoquinol USA® , a world-class developer of veterinarian-approved ... EQUISTRO line, at this week’s Rolex Kentucky Three-Day Event in Lexington. Flexadin UCII ... The scientifically-developed Flexadin UCII supports the body’s normal repair of cartilage and joints. ...
(Date:4/24/2017)... ... April 24, 2017 , ... LG ... Your Own Device (BYOD) capabilities at Telehealth 2.0, the American Telemedicine Association’s national ... which pairs medical devices with a pre-programmed tablet in a remarkably easy-to-use kit ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017 Cardiology devices segment is ... period The Cardiology Devices segment is likely to ... 15 Mn in 2018 over 2017. By the end of ... valuation close to US$ 700 Mn, expanding at a CAGR ... dominated the Asia Pacific reprocessed medical ...
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... HANOVER, N.J. , April 19, 2017 /PRNewswire/ ... conducted by the National Heart, Lung, and Blood ... (NIH) demonstrating that 58% of patients with treatment-naïve ... six months when treated with eltrombopag at the ... 1 . The study evaluated three sequential treatment ...
Breaking Medicine Technology: